Skip to content
MarketScale
‹ Back to IndustriesSciences

Should Scientists Be Doing More to Promote Science as a Global Enterprise?

It is said that science is a mosaic of contributions from all over the world. Modern science has, however, been hailed as a product of Western civilization for centuries, with the narrative of its history centered around seventeenth-century European gentlemen, who distinguished themselves from the scholastic schoolmen of yore by seeking to uncover the…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Eastern ScienceGlobalizationInternational CooperationScientific Knowledge
Share

Key takeaways

01

It is said that science is a mosaic of contributions from all over the world.

02

Modern science has, however, been hailed as a product of Western civilization for centuries, with the narrative of its history centered around seventeenth-century European gentlemen, who distinguished themselves from the scholastic schoolmen of yore by seeking to uncover the…

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Start free

It is said that science is a mosaic of contributions from all over the world. Modern science has, however, been hailed as a product of Western civilization for centuries, with the narrative of its history centered around seventeenth-century European gentlemen, who distinguished themselves from the scholastic schoolmen of yore by seeking to uncover the laws of nature. This narrative has provided a powerful resource to explain the economic and political hegemony of Europe in the centuries to follow. But how accurate is the idea and notion of formulating science as a product of Western attitudes? And if that’s not the case, is it more incumbent than ever for the science community at large to help the world regard science as a global enterprise?

Recent publications from the last few months, including Horizons from James Poskett, Associate Professor in the History of Science and Technology at the University of Warwick, and From Lived Experience to the Written Word from Pamela H. Smith, founding director of the Center for Science and Society, are making it a point to challenge these narrative foundations that guide the West’s conception of scientific achievement. Looking at a wider scale, science has roots in ancient civilizations from all over the world. From the Indian subcontinent to ancient China, scholars have made contributions to various fields of science for thousands of years. In fact, many of the scientific advancements that we attribute to Western civilization today would not have been possible without the contributions of scholars from other parts of the world. Algebra and geometry, for instance, were developed in the Arab world. In addition, the invention of paper and printing technology in China enabled the spread of knowledge across the globe.

Globalization has made it easier than ever for scientists to collaborate across borders and share knowledge. Today, research teams are made up of scientists from all over the world, but geopolitical tensions can get in the way of international collaboration. The UN, and even top Western economic organizations, highlight the need for collaboration in successful scientific research and innovation, which in the past has allowed for the rapid advancement of scientific knowledge and technologies that have the potential to benefit everyone on the planet.

Michael Pravica, Professor of Physics at the University of Nevada-Las Vegas, gave his sentiment that the recognition of the global nature of science is essential for the advancement of scientific knowledge and technologies that have the potential to benefit everyone on the planet.

Michael’s Thoughts

“First of all, science is by definition a natural philosophy. So it is the way that we cope as creatures that evolve from the natural world with how to survive and thrive in the natural world.

All human beings are scientists; we all have to cope with natural laws and physical laws to exist. And in fact, every single human being currently living on this planet is a miracle. The product of generations of other human beings are ancestors who have basically learned science well enough that they survived. They were able to grow food to exist. Science, by definition, like a living organism, is something that grows: it’s always being improved upon. It’s collaborative by nature because that’s how ideas often cross-germinate.

And so basically, science requires the sharing of knowledge. And that knowledge has been ongoing since the dawn of humankind, and not just in the West, but everywhere. And to give you an example of that knowledge, the Native Americans taught the pilgrims and other European Americans how to grow maize, which is essentially corn. And so, without that, they would not have survived here in North America without that ability for food. The Chinese invented gunpowder, and the unfortunate thing about gunpowder is that it was used to kill other humans. So sometimes those are not such good things, but the point is, it’s all science.

And the point, the essence here, is that now more than ever, we live in a world that is faced and set with critical problems such as climate change, pandemics, poisoning of our ecosphere, dwindling of natural resources, and overpopulation. One human being cannot solve the world’s problems. One scientist cannot solve the world’s problems. One nation cannot even solve the world’s problems. The essence is that we need all humanity on board to help solve these problems, to find the solutions, and then implement them.”

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Sciences Insights

CDMOs’ new capacity skews stainless by liters, but single-use leads by system count

CDMOs’ new capacity skews stainless by liters, but single-use leads by system count

Contract Pharma reports bioTRAK data projecting CDMOs will install roughly 120 bioreactors by 2030. It says 71% of added volume is large-scale stainless steel, while 61% of systems are single-use.

  • 01Utilization discipline is still driving builds: BioTRAK’s Dawn Ecker told Contract Pharma expansion conversations typically start after a site is booked above ~80% for several years.

Sep 22, 2026

Pharma supplier diversification means little if every supplier uses the same airport

Pharma supplier diversification means little if every supplier uses the same airport

Biocair's Patrick Wohl argues in Pharmaceutical Commerce that life sciences firms must map airports, sea lanes, customs gateways and carriers alongside suppliers. Suppliers spread across countries can still share one air hub. The fix he describes is pre-qualified alternate routes and continuous review, with clinical trial shipments and cold-chain medicines the first cargo exposed when a corridor closes.

  • 01A supplier base spread across several countries can still be a single point of failure if every shipment routes through one airport hub or corridor; the sharper question for a logistics provider is which hubs each qualified lane actually depends on.
  • 02Gartner data cited by MD+DI gives a benchmark: 42% of procurement leaders rank supply disruption as their organization's top risk, with geopolitical issues including tariffs and regulatory changes ranking third.
  • 03A route map ages fast. Pharmaceutical Commerce published the mapping argument on July 24 and was reporting fresh Red Sea and Iran-related freight risk for pharma lanes by Aug. 10, which is the case for treating mapping as a recurring review rather than a project.

Sep 17, 2026

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512